LogicBio Therapeutics (LOGC) Insider Trading & Ownership → A letter is coming from the 'Bureau of the Fiscal Service'. (From Stansberry Research) (Ad) Free LOGC Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Insider TradesStock AnalysisCompetitorsInsider TradesOptions ChainSocial MediaSustainabilityStock AnalysisCompetitorsInsider TradesOptions ChainSocial MediaSustainability LogicBio Therapeutics (NASDAQ:LOGC) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage8.10%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)1Amount OfInsider Selling(Last 12 Months)$24,641.16 Get LOGC Insider Trade Alerts Want to know when executives and insiders are buying or selling LogicBio Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address LOGC Insider Buying and Selling by Quarter Ad The Freeport SocietyPOTUS in ‘25 Not Biden/Trump, ButAnd I believe when they do take the oath of office, their fingers will be crossed… and America will descend into chaos.Click here now to see my urgent election warning. LogicBio Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails8/9/2021Daniel GruskinInsiderSell1,467$4.35$6,381.45 (Data available from 1/1/2013 forward) LOGC Insider Trading Activity - Frequently Asked Questions Who is on LogicBio Therapeutics's Insider Roster? The list of insiders at LogicBio Therapeutics includes Brett Just, and Daniel Gruskin. Learn more on insiders at LOGC. What percentage of LogicBio Therapeutics stock is owned by insiders? 8.10% of LogicBio Therapeutics stock is owned by insiders. Learn more on LOGC's insider holdings. Which LogicBio Therapeutics insiders have been selling company stock? The following insider sold LOGC shares in the last 24 months: Brett Just ($24,641.16). How much insider selling is happening at LogicBio Therapeutics? Insiders have sold a total of 4,369 LogicBio Therapeutics shares in the last 24 months for a total of $24,641.16 sold. More Insider Trading Tools from MarketBeat Related Companies: Ikena Oncology Insider Selling Turnstone Biologics Insider Selling Elutia Insider Selling Atara Biotherapeutics Insider Selling Precision BioSciences Insider Selling Entera Bio Insider Selling Cidara Therapeutics Insider Selling LENZ Therapeutics Insider Selling Aligos Therapeutics Insider Selling Cognition Therapeutics Insider Selling Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: 4 Small-Cap Energy Stocks Insiders are Buying 3 Penny Stocks That Insiders Are BuyingThe 3 Hottest Insiders Buys This Month 3 Companies Buying Back Cheap Stock LatelyPagaya Technologies: An AI Fintech That Insiders Are Buying This page (NASDAQ:LOGC) was last updated on 5/18/2024 by MarketBeat.com Staff From Our Partners[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingMake this ONE trade on Tuesday at 2 p.m. EST!Monument Traders AllianceThe Presidential candidate you should REALLY be worried aboutStansberry ResearchProtect Your Bank Account Before It’s Too LateWeiss RatingsForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressWhat’s Really Next for America…Porter & CompanyHe called Apple at $1.49 and now he says: “Buy these 6 AI stocks.”InvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LogicBio Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
